Full Text View
Tabular View
No Study Results Posted
Related Studies
A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults
This study has been completed.
Study NCT00057525   Information provided by DynPort Vaccine Company LLC, A CSC Company
First Received: April 3, 2003   Last Updated: January 25, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anthrax
More general conditions related to this trial
Bacillaceae Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Interventions listed in this trial
Vaccine
Sponsors listed in this trial
DynPort Vaccine Company LLC, A CSC Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services